THE INCIDENCE OF SARS-COV-2 INFECTION IN PATIENTS WITH RHEUMATIC DISEASES ON THERAPY BIOLOGICAL DISEASE MODIFYING ANTIRHEUMATIC DRUGS

被引：0
|
作者：
Dadalova, A. [1 ]
Vasilenko, E. [1 ]
Samigullina, R. [1 ]
Mazurov, V. [1 ]
机构：
[1] North Western State Med Univ, Dept Therapy Rheumatol Examinat Temporary Disabil, St Petersburg, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.4323
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0712
引用
收藏
页码：1387 / 1388
页数：2
相关论文
共 50 条
  • [1] Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases
    Zingarelli, S.
    Airo, P.
    Frassi, M.
    Bazzani, C.
    Scarsi, M.
    Puoti, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (01) : S83 - S83
  • [2] Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases
    Zingarelli, S.
    Airo, P.
    Frassi, M.
    Bazzani, C.
    Scarsi, M.
    Puoti, M.
    REUMATISMO, 2008, 60 (01) : 22 - 27
  • [3] Oral disease-modifying antirheumatic drugs and immunosuppressants with antiviral potential, including SARS-CoV-2 infection: a review
    Tsai, Y. C.
    Tsai, T. F.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2020, 12
  • [4] Implications of SARS-CoV-2 infection for patients with rheumatic disease
    Lin, Changsong
    Wang, Ziyu
    Li, Jie
    Xia, Xinyi
    Liu, Yun
    Wang, Qianghu
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (08)
  • [5] IS BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG USE IN PATIENTS WITH AUTOIMMUNE DISEASES A RISK FACTOR FOR SEVERE SARS-COV-2 INFECTION?
    Waqar, Hafiza Hareem
    Mahmood, Fatima
    Nautiyal, Amit
    CHEST, 2022, 162 (04) : 1856A - 1857A
  • [6] Risk factors for SARS-CoV-2 infection in patients with rheumatic diseases
    Snarska, Weronika
    Jurkowska, Zuzanna
    Bobrowska-Snarska, Danuta
    Brzosko, Marek
    Przepiera-Bedzak, Hanna
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2021, 131 (12):
  • [7] ADHERENCE TO DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATIC DISEASES
    Pineda Sic, Rita Angelica
    de Jesus Hernandez-Galarza, Ivan
    Castro-Gonzalez, Marielva
    Angel Galarza-Delgado, Dionicio
    Angel Villarreal-Alarcon, Miguel
    Allan Uriarte Botello, Rodolfo
    Ilizaliturri Guerra, Octavio
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1681 - 1681
  • [8] Accelerated Waning of Protective Immunity After SARS-CoV-2 mRNA Vaccination in Patients Treated with Biological and Targeted Synthetic Disease Modifying Antirheumatic Drugs
    Simader, Elisabeth
    Tobudic, Selma
    Deimel, Thomas
    Mandl, Peter
    Haslacher, Helmuth
    Perkmann, Thomas
    Schneider, Lisa
    Nothnagl, Thomas
    Radner, Helga
    Winkler, Florian
    Burgmann, Heinz
    Stiasny, Karin
    Novacek, Gottfried
    Reinisch, Walter
    Aletaha, Daniel
    Winkler, Stefan
    Blueml, Stephan
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1840 - 1842
  • [9] ACCELERATED WANING OF PROTECTIVE IMMUNITY AFTER SARS-COV-2 MRNA VACCINATION IN PATIENTS TREATED WITH BIOLOGICAL AND TARGETED SYNTHETIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS
    Tobudic, S.
    Simader, E.
    Deimel, T.
    Mandl, P.
    Haslacher, H.
    Perkmann, T.
    Schneider, L.
    Nothnagl, T.
    Lechner-Radner, H.
    Winkler, F.
    Burgmann, H.
    Stiasny, K.
    Novacek, G.
    Reinisch, W.
    Aletaha, D.
    Winkler, S.
    Blueml, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 955 - 956
  • [10] Adherence to biologic disease-modifying antirheumatic drugs in adult patients with rheumatic diseases
    Fazaa, Alia
    Makhlouf, Yasmine
    Ben Ouhiba, Amad
    Miladi, Saoussen
    Sellami, Mariem
    Ouenniche, Kmar
    Souabni, Leila
    Kassab, Salma
    Chekili, Selma
    Zakraoui, Leith
    Ben Abdelghani, Kawther
    Laatar, Ahmed
    THERAPIE, 2021, 76 (05): : 467 - 474
12345